Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 205-209 , April 2010

N-3 vs. saturated fatty acids: Effects on the arterial wall

References 

  1. Hansen S, Harris W. New evidence for the cardiovascular benefits of long chain omega-3 fatty acids. Curr. Atheroscler. Rep. 2007;9:434–440
  2. Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 2006;84:5–17
  3. Harper CR, Jacobson TA. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Am. J. Cardiol. 2005;96:1521–1529
  4. He K, Liu K, Daviglus M, et al. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am. J. Clin. Nutr. 2008;88:1111–1118
  5. Racine RA, Deckelbaum RJ. Sources of the very-long-chain unsaturated omega-3 fatty acids: eicopentaenoic acid and docohexaenoic acid. Curr. Opin. Clin. Nutr. Metab. Care. 2007;10:123–128
  6. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355–1374
  7. Rader DJ. Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol. 2003;92:42J–49J
  8. Yu K, Mamo J. Chylomicron-remnant-induced foam cell formation and cytotoxicity: a possible mechanism of cell death in atherosclerosis. Clin. Sci. (London). 2000;98:183–192
  9. Botham K, Bravo E, Elliott J, Wheeler-Jones C. Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development. Curr. Pharm. Des. 2005;11:3681–3695
  10. De Pascale C, Avella M, Perona J, et al. Fatty acid composition of chylomicron remnant-like particles influences their uptake and induction of lipid accumulation in macrophages. FEBS J. 2006;273:5632–5640
  11. De Pascale C, Graham V, Fowkes R, Wheeler-Jones C, Botham K. Suppression of nuclear factor-kappaB activity in macrophages by chylomicron remnants: modulation by the fatty acid composition of the particles. FEBS J. 2009;276:5689–5702
  12. Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005;352:1685–1695
  13. Babaev VR, Fazio S, Gleaves LA, et al. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J. Clin. Invest. 1999;103:1697–1705
  14. Rumsey SC, Obunike JC, Arad Y, Deckelbaum RJ, Goldberg IJ. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J. Clin. Invest. 1992;90:1504–1512
  15. Seo T, Velez-Carrasco W, Qi K, et al. Selective uptake from LDL is stimulated by unsaturated fatty acids and modulated by cholesterol content in the plasma membrane: role of plasma membrane composition in regulating non-SR-BI-mediated selective lipid transfer. Biochemistry. 2002;41:7885–7894
  16. Seo T, Qi K, Chang C, et al. Saturated fat-rich diet enhances selective uptake of LDL cholesteryl esters in the arterial wall. J. Clin. Invest. 2005;115:2214–2222
  17. Chang CL, Seo T, Matsuzaki M, Worgall TS, Deckelbaum RJ. n-3 Fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution. Arterioscler. Thromb. Vasc. Biol. 2009;29:555–561
  18. Mead J, Cryer A, Ramji D. Lipoprotein lipase, a key role in atherosclerosis?. FEBS Lett. 1999;462:1–6
  19. Renier G, Skamene E, DeSanctis J, Radzioch D. High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. Arterioscler. Thromb. 1993;13:190–196
  20. Michaud SE, Renier G. Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs. Diabetes. 2001;50:660–666
  21. Ross R. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 1999;340:115–126
  22. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 2000;342:836–843
  23. Hwang S, Ballantyne C, Sharrett A, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96:4219–4225
  24. Ridker P, Hennekens C, Roitman-Johnson B, Stampfer M, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998;351:88–92
  25. Blake G, Ridker P. Inflammatory bio-markers and cardiovascular risk prediction. J. Intern. Med. 2002;252:283–294
  26. Miles E, Banerjee T, Calder P. The influence of different combinations of gamma-linolenic, stearidonic and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers. Prostaglandins Leukot. Essent. Fatty Acids. 2004;70:529–538
  27. Lee T, Hoover R, Williams J, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 1985;312:1217–1224
  28. Gibney M, Hunter B. The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur. J. Clin. Nutr. 1993;47:255–259
  29. Healy D, Wallace F, Miles E, Calder P, Newsholm P. Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids. 2000;35:763–768
  30. Calder P, Bond J, Harvey D, Gordon S, Newsholme E. Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem. J. 1990;269:807–814
  31. Miles EA, Calder PC. Modulation of immune function by dietary fatty acids. Proc. Nutr. Soc. 1998;57:277–292
  32. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids. 2007;77:327–335
  33. Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br. J. Pharmacol. 2009;158:960–971
  34. Bannenberg G, Chiang N, Ariel A, et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 2005;174:4345–4355
  35. Serhan C, Clish C, Brannon J, et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 2000;192:1197–1204
  36. Chen Y, Wang J, Nie R, Zhou S. Endogenous pro-resolving and anti-inflammatory lipid mediators: the new hope of atherosclerotic diseases. Med. Hypotheses. 2008;71:237–240
  37. Dona M, Fredman G, Schwab JM, et al. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood. 2008;112:848–855
  38. Shagdarsuren E, Djalali-Talab Y, Aurrand-Lions M, et al. Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice-brief report. Arterioscler. Thromb. Vasc. Biol. 2009;29:1161–1163
  39. Butcher E. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991;67:1033–1036
  40. Butcher E. Leukocyte–endothelial cell adhesion as an active, multi-step process: a combinatorial mechanism for specificity and diversity in leukocyte targeting. Adv. Exp. Med. Biol. 1992;323:181–194
  41. Kansas G. Selectins and their ligands: current concepts and controversies. Blood. 1996;88:3259–3287
  42. Liu Y, Shaw S, Ma S, et al. Regulation of leukocyte transmigration: cell surface interactions and signaling events. J. Immunol. 2004;172:7–13
  43. Lawrence M, Springer T. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991;65:859–873
  44. Eriksson E, Xie X, Werr J, Thoren P, Lindbom L. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J. 2001;15:1149–1157
  45. S. Bannykh, J.Witztum , C.Bergmark, Mechanical aortic injury in apoE-deficient mice as a model for development of atherosclerosis: demonstration of leukocyte rolling early after injury, Ultrastruct. Pathol. 26 (2002) 251–260.
  46. Tull S, Yates C, Maskrey B, et al. Omega-3 fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment. PLoS Biol. 2009;7:e1000177
  47. Goncalves de Moraes V, Boris Vargaftig B, Lefort J, Meager A, Chignard M. Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung. Br. J. Pharmacol. 1996;117:1792–1796
  48. Hamada T, Tsuchihashi S, Avanesyan A, et al. Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury. J. Immunol. 2008;180:1843–1853
  49. Massaro M, Habib A, Lubrano L, et al. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc. Natl. Acad. Sci. USA. 2006;103:15184–15189
  50. A. Mullen, C. Loscher, H. Roche, Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages, J. Nutr. Biochem., 2009.
  51. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med. Indones. 2007;39:86–93
  52. Shiina T, Terano T, Saito J, Tamura Y, Yoshida S. Eicosapentaenoic acid and docosahexaenoic acid suppress the proliferation of vascular smooth muscle cells. Atherosclerosis. 1993;104:95–103
  53. Terano T, Shiina T, Tamura Y. Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals. Lipids. 1996;31:S301–S304
  54. Bermudez B, Lopez S, Pacheco YM, et al. Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery. Cardiovasc. Res. 2008;79:294–303
  55. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation. 2003;108:1664–1672
  56. Loree H, Kamm R, Stringfellow R, Lee R. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ. Res. 1992;71:850–858
  57. Burr M, Fehily A, Gilbert J, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757–761
  58. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 1999;130:554–562
  59. Thies F, Garry J, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003;361:477–485
  60. Alfonso F, Cequier A, Angel J, et al. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial. Am. Heart J. 2006;151:e681–e689
  61. Bang HO, Deyerberg J, Nielsen AB. Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet. 1971;1:1143–1145
  62. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet. 1979;2:433–435
  63. von Schacky C. A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vasc. Health Risk Manage. 2006;2:251–262

☆ Sources of support in the form of grants: NIH Grant #HL40404

PII: S0952-3278(10)00064-5

doi: 10.1016/j.plefa.2010.02.020

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 205-209 , April 2010

Article Tools